These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 6447586

  • 21. The effect of vagolytic drugs on airway obstruction in patients with bronchial asthma.
    Firstater E, Mizrachi E, Topilsky M.
    Ann Allergy; 1981 Jun; 46(6):332-5. PubMed ID: 6454371
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Effect of ipratropium bromide on mucociliary clearance and pulmonary function in reversible airways obstruction.
    Pavia D, Bateman JR, Sheahan NF, Clarke SW.
    Thorax; 1979 Aug; 34(4):501-7. PubMed ID: 159510
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Diurnal rhythm of bronchial patency and administration of atrovent].
    Zamotaev IP, Maksimova LN.
    Klin Med (Mosk); 1985 Jun; 63(6):84-6. PubMed ID: 3162059
    [No Abstract] [Full Text] [Related]

  • 26. [Effect of the inhalation of an atropine derivative (ipratropium bromide) in powder form on respiratory mechanics in obstructive airway diseases].
    Götz R, Siemon G.
    Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():927-8. PubMed ID: 6227883
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Sputum viscosity and long-term ipratropium bromide nebuliser therapy.
    Crompton GK.
    Lancet; 1982 May 29; 1(8283):1243. PubMed ID: 6122995
    [No Abstract] [Full Text] [Related]

  • 30. [Effect of cholinergic blockade with Atrovent on pulmonary function in people with asthma].
    Szczeklik A, Adamek-Guzik T, Czerniawska-Mysik G, Nizankowska E, Pietoń R.
    Pol Tyg Lek; 1977 Apr 18; 32(16):611-4. PubMed ID: 140370
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Safety of Atrovent.
    Lichterfeld A.
    Scand J Respir Dis Suppl; 1979 Apr 18; 103():143-7. PubMed ID: 155289
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Ipratropium for chronic bronchitis.
    Flacks LM.
    N Z Med J; 1980 Mar 26; 91(656):232-3. PubMed ID: 6446049
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Optimal bronchodilation by increasing the dosage of the atropine component? (author's transl)].
    Zimmermann I, Ulmer WT.
    Prax Klin Pneumol; 1977 Jun 26; 31(6):603-7. PubMed ID: 141662
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Nebulised ipratropium bromide and salbutamol in chronic bronchitis.
    Lees AW, Allan GW, Smith J.
    Br J Clin Pract; 1980 Jun 26; 34(11-12):340-2. PubMed ID: 6450601
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.